Difenamizole is a nonsteroidal anti-inflammatory drug (NSAID), which is a pyrazolinone analgesic drug-related to Analgin. It has monoaminergic properties, including inhibition of monoamine oxidase, an increase of pargyline-induced striatal dopamine levels, inhibition of K+ -induced striatal dopamine release, and inhibition of dopamine reuptake.

20170-20-1

C20H22N4O

334.41

Diphenamizole;Difenamizolum;Pasalin;BRN 0698538;Difenamizole

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years